Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
12 employees
Conceivable Life Sciences: Automating IVF labs for accessible fertility treatments.
HQ
Founded
2022
Conceivable Life Sciences was founded with the mission to democratize access to in vitro fertilization (IVF) by building the first fully automated IVF lab. The company's vision is to make the highest quality fertility treatments available to all, addressing the significant gap in accessibility. Conceivable Life Sciences focuses on leveraging advanced technology to overhaul traditional IVF processes, aiming to provide affordable and efficient fertility solutions to millions of people worldwide who struggle with infertility.
Notable figures affiliated with Conceivable Life Sciences include experts in reproductive medicine and technology innovation. The company has garnered attention from investors interested in healthcare and technological advancements. Key achievements include the development of proprietary automation technology that significantly reduces the cost and complexity of IVF procedures. The overall impact of Conceivable Life Sciences lies in its potential to transform the fertility treatment landscape, making it possible for a greater number of intended parents to realize their dreams of having children.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Fertility Treatments
Technology
Automation, Robotics
Tags
Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
Global
When was Conceivable Life Sciences founded?
Conceivable Life Sciences was founded in 2022.
Where is Conceivable Life Sciences's headquarters located?
Conceivable Life Sciences's headquarters is located in Milton Keynes, BKM, GB.
When was Conceivable Life Sciences's last funding round?
Conceivable Life Sciences's most recent funding round was for $20M (USD) in August 2023.
How many employees does Conceivable Life Sciences have?
Conceivable Life Sciences has 12 employees as of Feb 5, 2024.
How much has Conceivable Life Sciences raised to-date?
As of July 05, 2023, Conceivable Life Sciences has raised a total of $20M (USD) since Aug 1, 2023.
Add Comparison
Total Raised to Date
$20M
USD
Last Update Aug 1, 2023
Last Deal Details
$20M
USD
Aug 1, 2023
Seed
Current Employees
12
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts